Development of Prognostic Gene Panels: Subtype Prediction & Risk Stratification in Breast Cancer

Prognostic and Predictive Gene Panels

Development of Prognostic Gene Panels: Subtype Prediction & Risk Stratification in Breast Cancer

In this work, we have developed a robust and cost-efficient biomarker with a set of only six genes (Pattern BC06) that can predict both survival and subtypes with an accuracy of 86%. Our biomarker panel will allow an improved understanding of clinical implications of molecular subtypes and risk prediction that could help clinicians guide precision medicine, tailoring medical treatment to patients and their tumor characteristics.

Read the paper here